You are here: Industry Insights > Therapies

News List

What's happening in HF therapies Neeta Ratanghayra
January 02, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.The severity of the disease warrants the development of innovative solutions to address the current treatment gap.
ATMPS, Assurea Launch Strategic Supply Chain Pact contractpharma
December 13, 2021
Aims to offer a fully complaint plug and play ready blockchain solution for end-to-end supply chain management of cell and gene therapies.
Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies worldpharmanews
August 14, 2019
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for various types of cancers,
VGXI, Geneos Establish Supply Agreement contractpharma
July 24, 2019
Plasmid DNA manufacturer VGXI to support production of personalized cancer therapies as part of a long-term supply agreement with Geneos.
Convelo, Genentech to Collaborate on Remyelinating Therapies contractpharma
July 18, 2019
Aims to treat patients with neurological disorders such as multiple sclerosis.
Intra-Cellular Therapies Announces Positive Phase III Results contractpharma
July 17, 2019
Lumateperone achieves topline results in the treatment of major depressive episodes associated with Bipolar I or Bipolar II disorder.
Gilead and Nurix to Collaborate on Novel Therapies contractpharma
June 21, 2019
Consisting of targeted protein degradation drugs for patients with cancer and other challenging diseases.
FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer worldpharmanews
June 06, 2019
The U.S. Food and Drug Administration Oncology Center of Excellence announced a new pilot program to assist oncology health care professionals in requesting access to unapproved therapies for patients with cancer.
FDA Announces Project for Doctors to Access Unapproved Therapies for Cancer Patients americanpharmaceuticalreview
June 06, 2019
The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence announced a new pilot program to assist oncology health care professionals in requesting access to unapproved therapies for patients with cancer.
Experts Develop Standardized Tool for Describing Cell Therapies drugs
May 31, 2019
Experts develop standardized tool for describing cell therapies.

Previous page 1 2 Next page